About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Insights from 2024 EHA Annual Meeting
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and EHA
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Kerry Rogers
,
Jennifer Woyach
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Kerry Rogers
,
Jennifer Woyach
6 views
June 21, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Videos
14:32
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Infectious Complications in BCMA- and GPRC5D-Targ…
Feat.
J. Mersi
03:52
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: FLAG-GO vs. FLAG-IDA in Untreated Core Binding Fa…
Feat.
G. Borthakur
04:03
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: PROs After Epcoritamab in R/R Follicular Lymphoma
Feat.
W. Jurczak
05:27
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Updated Trends in Real-World Outpatient Administr…
Feat.
R. Bansal
06:39
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Axicabtagene Ciloleucel in R/R Primary Mediastina…
Feat.
J. Galtier
12:32
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Sequential Administration of Bispecific Antibodie…
Feat.
D. Fandrei
06:51
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL W…
Feat.
W. Jurczak
10:03
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SEQUOIA Trial Arm D - Zanubrutinib + Venetoclax f…
Feat.
P. Ghia
12:04
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: The Impact of TP53 Mutation Burden on Risk & …
Feat.
M. Salamoon
06:54
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: CD20-Targeted CAR-T Therapy for BTKi-Refractory W…
Feat.
M. Shadman
05:41
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Advantages of Using Venetoclax-Based Therapy in H…
Feat.
C. Coombs
06:30
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ A…
Feat.
E. Oliva
11:23
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Final 5-Year Results of Olutasidenib for Mutated …
Feat.
J. Cortés
14:39
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: REVIVE Study - Updated Long-Term Results of Hepci…
Feat.
K. Pettit
04:33
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Daratumumab for iTTP
Feat.
J. Weisinger
36:10
Insights from 2024 EHA Annual Meeting
Highlights in Plasma Cell Disorders From ASCO® and EHA
Feat.
S. Al Hadidi
09:52
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: AML Highlights - Focus on Menin Inhibitors
Feat.
J. Zeidner
11:40
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: FLAG-IDA + Venetoclax in Newly Diagnosed or R/R A…
Feat.
W. Jen
10:27
Insights from 2024 EHA Annual Meeting
Responder Analysis From the PhALLCON Trial: Ponatinib vs. Imatinib i…
Feat.
J. Ribera
19:14
2024 ASCO® Annual Meeting Insights Hub
Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and E…
Feat.
K. Rogers,
J. Woyach
07:38
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: TRANSCEND NHL 001 Study - Liso-Cel in R/R MCL - A…
Feat.
M. Kamdar
12:24
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: PERSEUS Trial MRD Analysis: Dara + VRd in Transpl…
Feat.
P. Sonneveld
12:00
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: QUAZAR AML-001 - Oral Azacitidine Maintenance in …
Feat.
M. Teresa Voso